Skip to main content
15/09/2009 - 11:13

BioPharmica plans IPO for subsidiary

15/09/2009 - 11:13

Bookmark

Save articles for future reference.

Perth-based biotechnology outfit BioPharmica plans to seek an initial public offer for its wholly owned subsidiary, Molecular Discovery Systems, which will focus on cancer treatments.

X

To read our articles you will need to either login or subscribe.